GLP-1 medications like Ozempic and Wegovy help protect heart health, but stopping the medications may reduce the protective effects
To view or add a comment, sign in GLP1, Wegovy, has recently been FDA-approved for MASH patients with moderate-to-advanced fibrosis hot on the heels of last years approval of first-mover, Rezdifrra
Tirzepatide while breastfeeding Tirzepatide (Zepbound) is an even larger molecule than semaglutide, which is why most healthcare experts expect low transfer into breast milk
A dermatologist can distinguish between the two types through examination and, if needed, scalp biopsy
First, the risk profile of patients enrolled in the RCTs does not necessarily match that of patients for whom we are considering weighing the long-term benefits and potential harms